摘要:武田制药及其全资子公司武田制药(北美)公司宣布,FDA已批准该公司的dexlansoprazole(Kapidex)口服缓释胶囊每日一次用于治疗胃食管返流病(GERD)引起的胃灼热症状、腐蚀性食管炎(EE)治疗和愈后腐蚀性食管炎的维持治疗。Kapidex有30mg和60mg两种规格,是第一个质子泵抑制剂双重控释片,药物成分可以分两次单独释放。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Journal of Huazhong University of Science and Technology The Journal of China Universities of Posts and Telecommunications Journal of Genetics and Genomics Journal of Iron and Steel Research Journal of Systems Science and Complexity World Journal of Gastroenterology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities International Journal of Minerals Metallurgy and Materials International Journal of Mining Science and Technology Journal of Systems Science and Systems Engineering